(Q33509787)

27 July 2017

1 reference

title

Updates on the pathophysiology and management of acne rosacea (English)

1 reference

27 July 2017

1 reference

Mohamed L Elsaie

1

0 references

author name string

Sonal Choudhary

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

27 July 2017

published in

Postgraduate Medicine

1 reference

27 July 2017

volume

121

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

178-186

1 reference

Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Azelaic acid (15% gel) in the treatment of acne rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Systematic review of rosacea treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Topical metronidazole. A review of its use in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Treatment of rosacea by metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Current topical and systemic approaches to treatment of rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Photodynamic therapy in the treatment of rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

The effect of azithromycin on reactive oxygen species in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Effect of antibiotics on the generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Functional changes induced by chronic UVA irradiation to cultured human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Myeloid differentiation factor 88 regulates basal and UV-induced expressions of IL-6 and MMP-1 in human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Tetracyclines: nonantibiotic properties and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

The significance of Demodex folliculorum density in rosacea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Helicobacter pylori Heat Shock Protein 60 Mediates Interleukin-6 Production by Macrophages via a Toll-like Receptor (TLR)-2-, TLR-4-, and Myeloid Differentiation Factor 88-independent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Comparative study of some treatment modalities of rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

The clinical importance of demodex folliculorum presenting with nonspecific facial signs and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

Efficacy of topical cyclosporine for the treatment of ocular rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.09.2066

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.09.2066

1 reference

27 July 2017

1 reference